MetaCap

ADARx Pharmaceuticals Insider Trades

NASDAQ: ADRXHealth CareBiotechnology: Pharmaceutical PreparationsUSD

12.79-1.37 (-9.68%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
13 · $87.75M
Sales
0 · $0
Shares bought / sold
5.16M / 0
Net activity
Net buying $87.7 million

ADARx Pharmaceuticals insider activity

Over the last 12 months, ADARx Pharmaceuticals insiders reported 51 transactions on SEC Form 4: 13 open-market purchases and 0 sales. Insiders bought $87.7 million and sold $0 worth of stock, for net insider buying of $87.7 million. The most recent filing shows Chimovits Erez (Director) reporting a transaction in 7,127,019 shares on Sep 28, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put ADRX's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

ADRX insider transactions

ADARx Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Sep 28, 2026LAV Biosciences Fund V, L.P. & LAV Fund VI Opportunities, L.P. & LAV Fund VI, L.P.10% OwnerConversion307,738—Form 4
Sep 28, 2026LAV Biosciences Fund V, L.P. & LAV Fund VI Opportunities, L.P. & LAV Fund VI, L.P.10% OwnerConversion307,738—Form 4
Sep 28, 2026LAV Biosciences Fund V, L.P. & LAV Fund VI Opportunities, L.P. & LAV Fund VI, L.P.10% OwnerConversion153,868—Form 4
Sep 28, 2026LAV Biosciences Fund V, L.P. & LAV Fund VI Opportunities, L.P. & LAV Fund VI, L.P.10% OwnerConversion513,067—Form 4
Sep 28, 2026LAV Biosciences Fund V, L.P. & LAV Fund VI Opportunities, L.P. & LAV Fund VI, L.P.10% OwnerConversion1,667,469—Form 4
Sep 28, 2026LAV Biosciences Fund V, L.P. & LAV Fund VI Opportunities, L.P. & LAV Fund VI, L.P.10% OwnerConversion8,908,775—Form 4
Sep 28, 2026George SimeonDirectorBuy592,593$10.07MForm 4
Sep 28, 2026George SimeonDirectorConversion169,001—Form 4
Sep 28, 2026George SimeonDirectorConversion1,667,468—Form 4
Sep 28, 2026George SimeonDirectorBuy414,814$7.05MForm 4
Sep 28, 2026George SimeonDirectorConversion1,538,691—Form 4
Sep 28, 2026George SimeonDirectorBuy592,593$10.07MForm 4
Sep 28, 2026George SimeonDirectorConversion512,897—Form 4
Sep 28, 2026George SimeonDirectorConversion1,113,666—Form 4
Sep 28, 2026George SimeonDirectorConversion3,334,938—Form 4
Sep 28, 2026SR ONE CAPITAL MANAGEMENT, LLC10% OwnerBuy592,593$10.07MForm 4
Sep 28, 2026SR ONE CAPITAL MANAGEMENT, LLC10% OwnerConversion169,001—Form 4
Sep 28, 2026SR ONE CAPITAL MANAGEMENT, LLC10% OwnerConversion1,667,468—Form 4
Sep 28, 2026SR ONE CAPITAL MANAGEMENT, LLC10% OwnerBuy414,814$7.05MForm 4
Sep 28, 2026SR ONE CAPITAL MANAGEMENT, LLC10% OwnerConversion1,538,691—Form 4
Sep 28, 2026SR ONE CAPITAL MANAGEMENT, LLC10% OwnerBuy592,593$10.07MForm 4
Sep 28, 2026SR ONE CAPITAL MANAGEMENT, LLC10% OwnerConversion512,897—Form 4
Sep 28, 2026SR ONE CAPITAL MANAGEMENT, LLC10% OwnerConversion1,113,666—Form 4
Sep 28, 2026SR ONE CAPITAL MANAGEMENT, LLC10% OwnerConversion3,334,938—Form 4
Sep 28, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirectorBuy588,235$10.00MForm 4
Sep 28, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirectorBuy61,516$1.05MForm 4
Sep 28, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirectorConversion256,448—Form 4
Sep 28, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirectorConversion513,067—Form 4
Sep 28, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirectorConversion1,333,975—Form 4
Sep 28, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirectorConversion7,127,019—Form 4
Sep 28, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirectorBuy300,249$5.10MForm 4
Sep 28, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirectorConversion564,187—Form 4
Sep 28, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirectorConversion769,601—Form 4
Sep 28, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirectorConversion2,000,962—Form 4
Sep 28, 2026ORBIMED ADVISORS LLC & OrbiMed Capital GP VII LLC & OrbiMed Israel GP II, L.P. & OrbiMed Advisors Israel II Ltd & OrbiMed Genesis GP LLCDirectorConversion10,690,530—Form 4
Sep 28, 2026GORDON CARL LDirectorBuy588,235$10.00MForm 4
Sep 28, 2026GORDON CARL LDirectorBuy61,516$1.05MForm 4
Sep 28, 2026GORDON CARL LDirectorConversion256,448—Form 4
Sep 28, 2026GORDON CARL LDirectorConversion513,067—Form 4
Sep 28, 2026GORDON CARL LDirectorConversion1,333,975—Form 4
Sep 28, 2026GORDON CARL LDirectorConversion7,127,019—Form 4
Sep 28, 2026GORDON CARL LDirectorBuy300,249$5.10MForm 4
Sep 28, 2026GORDON CARL LDirectorConversion564,187—Form 4
Sep 28, 2026GORDON CARL LDirectorConversion769,601—Form 4
Sep 28, 2026GORDON CARL LDirectorConversion2,000,962—Form 4
Sep 28, 2026GORDON CARL LDirectorConversion10,690,530—Form 4
Sep 28, 2026Chimovits ErezDirectorBuy61,516$1.05MForm 4
Sep 28, 2026Chimovits ErezDirectorConversion256,448—Form 4
Sep 28, 2026Chimovits ErezDirectorConversion513,067—Form 4
Sep 28, 2026Chimovits ErezDirectorConversion1,333,975—Form 4
Sep 28, 2026Chimovits ErezDirectorConversion7,127,019—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related